Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $7.48 Million - $9.3 Million
30,854 Added 0.68%
4,560,483 $1.12 Billion
Q2 2022

Aug 12, 2022

SELL
$224.73 - $338.64 $7.89 Million - $11.9 Million
-35,124 Reduced 0.77%
4,529,629 $1.12 Billion
Q1 2022

May 12, 2022

SELL
$277.25 - $366.29 $7.71 Million - $10.2 Million
-27,813 Reduced 0.61%
4,564,753 $1.51 Billion
Q4 2021

Feb 10, 2022

BUY
$300.63 - $371.35 $86.4 Million - $107 Million
287,541 Added 6.68%
4,592,566 $1.65 Billion
Q3 2021

Nov 09, 2021

BUY
$310.19 - $376.2 $35.9 Million - $43.5 Million
115,689 Added 2.76%
4,305,025 $1.4 Billion
Q2 2021

Aug 11, 2021

BUY
$262.71 - $351.17 $1.1 Billion - $1.47 Billion
4,189,336 New
4,189,336 $1.31 Billion

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.